You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Crizanlizumab,

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Glioblastoma, Metastatic Melanoma in the CNS, MGMT-Unmethylated Glioblastoma Trial in Ramat Gan (Crizanlizumab-Tmca 10

Not yet recruiting
  • Advanced Glioblastoma
  • +2 more
  • Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
  • Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
  • Ramat Gan, Israel
    Sheba medical center
Jun 11, 2023

Sickle Cell Disease Trial (Crizanlizumab, control)

Not yet recruiting
  • Sickle Cell Disease
  • (no location specified)
Jul 19, 2022

Sickle Cell Disease Trial in Saint Louis (Crizanlizumab)

Recruiting
  • Sickle Cell Disease
  • Crizanlizumab
  • Saint Louis, Missouri
    Barnes-Jewish Hospital
Apr 11, 2022

Characteristics of Patients With Sickle Cell Disease

Completed
  • Sickle Cell Disease
  • Crizanlizumab
  • East Hanover, New Jersey
    Novartis Investigative Site
Aug 8, 2022

Real-world Setting: Preliminary Analysis From Select Sickle Cell

Completed
  • Sickle Cell Disease
    • Birmingham, Alabama
    • +10 more
    Apr 17, 2023

    Sickle Cell Disease Patients on Crizanlizumab Treatment in

    Recruiting
    • Sickle Cell Disease
    • Crizanlizumab
    • Manama, Bahrain
    • +5 more
    Jun 1, 2022

    RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy Trial in Saint Louis, Philadelphia (Crizanlizumab)

    Active, not recruiting
    • RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy
    • Saint Louis, Missouri
    • +1 more
    Jan 27, 2022

    COVID-19 Trial in Baltimore (Crizanlizumab, 0.9% saline)

    Completed
    Has Results
    • COVID-19
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Nov 3, 2021

    Sickle Cell Disease (SCD) Trial in India (crizanlizumab)

    Recruiting
    • Sickle Cell Disease (SCD)
    • Hyderabad, Andhra Pradesh, India
    • +7 more
    Mar 31, 2022

    Priapism Trial in United States (crizanlizumab)

    Recruiting
    • Priapism
    • Birmingham, Alabama
    • +18 more
    Jan 17, 2023

    Sickle Cell Disease Trial in Worldwide (Crizanlizumab)

    Recruiting
    • Sickle Cell Disease
    • Birmingham, Alabama
    • +19 more
    Jun 20, 2022

    Sickle Cell Disease (SCD) Trial in United States (crizanlizumab)

    Active, not recruiting
    • Sickle Cell Disease (SCD)
    • Orange City, Florida
    • +11 more
    Apr 25, 2022

    Sickle Cell Disease (SCD) Trial in Worldwide (Crizanlizuamb, Standard of Care)

    Active, not recruiting
    • Sickle Cell Disease (SCD)
    • Birmingham, Alabama
    • +24 more
    Jan 12, 2023

    Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)

    Suspended
    • Myelofibrosis
    • Adelaide, South Australia, Australia
    • +37 more
    Aug 18, 2022

    Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)

    Recruiting
    • Covid19
    • theraputic heparin
    • +4 more
    • Birmingham, Alabama
    • +101 more
    Jun 28, 2022